Hospital costs of colorectal cancer care

Clinical Medicine: Oncology

Volumn 2009, Issue 3, 2009, Pages 27-37

  Macafee, David A L ^a,c   West, J ^b   Scholefield, J H ^a   Whynes, D K ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Colorectal cancer; Cost; Dukes stage; Hospital; Screening

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HOSPITAL CARE; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NURSING CARE; RETROSPECTIVE STUDY; SEX RATIO; UNITED KINGDOM;

EID: 65649104510     PISSN: None     EISSN: 11779314     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Winterton R. Home test kits for bowel cancer. 2005 [cited 2/8/2005]. Available from:
2. Tuck J, Walker AR, Whynes DK, Pye G, Hardcastle JD, Chamberlain JO. Screening and the costs of treating colorectal cancer: some preliminary results. Public Health. 1989;103(6):413-9.
3. Whynes DK, Walker AR, Chamberlain JO, Hardcastle JD. Screening and the costs of treating colorectal cancer. British Journal of Cancer. 1993;68:965-8.
4. Loeve F, Brown ML, Boer R, Van Ballegooijen M, Van Oortmarssen GJ, Habbema DF. Endoscopic colorectal cancer screening: a cost-saving analysis. Journal of the National Cancer Institute. 2000; 92:557-63.
5. Frazier A, Colditz G, Fuchs C, Kuntz K. Cost effectiveness of screening for colorectal cancer in the general population. Journal of the American Medical Association. 2000;284:1954-61.
6. Ramsey SD, Mandelson MT, Berry K, Etzioni R, Harrison R. Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology. 2003;125:1645-1650.
7. Selke B, Durand I, Marissal JP, Chevalier D, Lebrun T. Cost of colorectal cancer in France in 1999. Gastroenterological Clinical Biology. 2003;27:22-27.
8. Whynes DK, Frew EJ, Edwards R, Atkin WS. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. International Journal of Technological Assessment in Health Care. 2003; 19(2):384-95.
9. Alexander F, Weller D. Evaluation of the U.K. Colorectal cancer screening pilot. In: www.cancerscreening.nhs.uk/colorectal/pilot.html, editor. Edinburgh; 2003.
10. Ward S, Salazano S, Sampson F, Cowan J. Improving supportive and palliative care to adults with cancer. [www.nice.org.uk/pdf/ csgspeconomicreview.pdf] 2004 [cited; 2-100]. Available from:
11. Renehan AG, O'Dwyer PJ, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. British Medical Journal. 2004;328:81-4.
12. Department of Health. NHS reference costs 2001. [Electronic] 2001 2002 [cited]; Available from:
13. HM Treasury. Gross Domestic Product (GDP) defl ator values. [Electronic] 2002 [cited]; Available from:
14. Bloor K, Maynard A, Freemantle N. Variation in activity rates of consultant surgeons and the influence of reward structures in the English NHS. Journal of Health Services Research and Policy. 2004;9(2):76-84.
15. Waller P, Shaw M, Ho D, Shakir S, Ebrahim S. Hospital admissions for "drug-induced" disorders in England: a study of Hospital Episodes Statistics (HES) database. British Journal of Clinical Pharmacology. 2005;59(2):213-9.
16. Ward S, Kaltenthaler E, Cowan J, Brewer N. Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation. Health Technology Assessment. 2003;7(32):1-122.
17. Kinsman R. Data analysis of Trent Wales Audit. London: Association of Coloproctologists of Great Britain and Ireland; 2001.
18. Sikora K, Bosanquet N. Cancer care in the United Kingdom: new solutions are needed. British Medical Journal. 2003;327:1044-6.
19. Brown M, Riley G, Potosky A. Obtaining long-term disease specific costs of care. Application to Medicare enrolees diagnosed with colorectal cancer. Medical Care. 1999;37:1249-59.
20. Coyle D, Small N, Ashworth A, Hennessy S, Jenkins-Clarke S, Mannion R, et al. Costs of palliative care in the community, in hospitals and in hospices in the U.K. Clinical reviews in Oncology/Haematology. 1999;32:71-85.
21. Secco GB, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. European Journal of Surgical Oncology. 2002;28(4):418-23.
22. Whynes DK, Walker AR, Hardcastle JD. Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas. Health Economics. 1992;1:53-60.
23. Hale JP, Cohen DR, Maughan TS, Stephens RJ. Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer. British Journal of Cancer. 2002;86:1684-1690.
24. Dixon J. Payment by results - new financial flows in the NHS. British Medical Journal. 2004;328:969-70.